This is a preview of subscription content, log in via an institution to check access.
Notes
2014 US dollars
Reference
Turner HC, et al. Investment success in public health: An analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis. Clinical Infectious Diseases : 12 Dec 2016. Available from: URL: http://doi.org/10.1093/cid/ciw835
Rights and permissions
About this article
Cite this article
GPELF measures cost effective for lymphatic filariasis. PharmacoEcon Outcomes News 769, 15 (2017). https://doi.org/10.1007/s40274-017-3651-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3651-2